PROM1 and brain neoplasm: The phosphorylated‐CD133 (p‐CD133) activated the phosphoinositide 3‐kinase (PI3K)‐Akt signaling pathway in brain tumor cells, in which the p‐CD133 level was elevated dependent on their grade of malignancy [17].